1: Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001 Oct 15;33(8):1417-23.
2: Webber MP, Schoenbaum EE, Farzadegan H, Klein RS. Tampons as a self-administered collection method for the detection and quantification of genital HIV-1. AIDS. 2001 Jul 27;15(11):1417-20.
3: Shrestha S, Strathdee SA, Brahmbhatt H, Farzadegan H, Vlahov D, Smith MW. Short tandem repeat methodology for genotypic identification of single-person versus multi-person use of syringes. AIDS. 2000 Jul 28;14(11):1507-13.
4: Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI. Consistent viral evolutionary changes associated with the progression of human
immunodeficiency virus type 1 infection. J Virol. 1999 Dec;73(12):10489-502.
5: Carneiro M, Yu XF, Lyles C, Templeton A, Weisstein AE, Safaeian M, Farzadegan H, Vlahov D, Markham RB.
The effect of drug-injection behavior on genetic evolution of HIV-1. J Infect Dis. 1999 Oct;180(4):1025-32.
6: Rompalo AM, Astemborski J, Schoenbaum E, Schuman P, Carpenter C, Holmberg SD, Warren DL, Farzadegan H, Vlahov D, Smith DK. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):448-54.
7: Lyles CM, Graham NM, Astemborski J, Vlahov D, Margolick JB, Saah AJ, Farzadegan H. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men. Eur J Epidemiol. 1999 Feb;15(2):99-108.
8: Rinaldo CR Jr, Gupta P, Huang XL, Fan Z, Mullins JI, Gange S, Farzadegan H, Shankarappa R, Munoz A, Margolick JB. Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection. AIDS Res Hum Retroviruses. 1998 Nov 1;14(16):1423-33.
9: Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, Quinn TC, Vlahov D.
Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 1998 Nov 7;352(9139):1510-4.
10: Lyles CM, Vlahov D, Farzadegan H, Astemborski J, Margolick JB, Masters BA, Schroeder J, Quinn TC.
Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups. J Clin Microbiol. 1998 Dec;36(12):3647-52.
11: Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu XF. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12568-73.
12: Yu XF, Wang Z, Vlahov D, Markham RB, Farzadegan H, Margolick JB. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection
drug users. J Infect Dis. 1998 Aug;178(2):388-96.
13: Dal Pan GJ, Farzadegan H, Selnes O, Hoover DR, Miller EN, Skolasky RL, Nance-Sproson TE, McArthur JC.
Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia.
J Neurovirol. 1998 Feb;4(1):95-9.
14: Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D. Vitamin A supplementation and human immunodeficiency virus load in injection drug users. J Infect Dis. 1998 Mar;177(3):611-6.
15: Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA. 1998 Jan 7;279(1):35-40.
16: Sharma UK, Song HF, Willingham FF, Hannig J, Flexner C, Farzadegan H, Nicolau C, Schwartz DH. Diagnosis of human immunodeficiency virus infection using citrated whole blood. Clin Diagn Lab Immunol. 1997 May;4(3):261-3.
17: Semba RD, Farzadegan H, Vlahov D. Vitamin A levels and human immunodeficiency virus load in injection drug users. Clin Diagn Lab Immunol. 1997 Jan;4(1):93-5.
18: Farzadegan H, Henrard DR, Kleeberger CA, Schrager L, Kirby AJ, Saah AJ, Rinaldo CR Jr, O'Gorman M, Detels R, Taylor E, Phair JP, Margolick JB. Virologic and serologic markers of rapid progression to AIDS after HIV-1
seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15;13(5):448-55.
19: Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis. 1996 Dec;174(6):1332-6.
20: Gupta P, Singh MK, Rinaldo C, Ding M, Farzadegan H, Saah A, Hoover D, Moore P, Kingsley L. Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma. AIDS. 1996 Nov;10(13):1596-8.
